118 related articles for article (PubMed ID: 22879494)
1. Medicine. Leveraging shear stress to bust clots with nanoparticles.
Lavik E; Ustin J
Science; 2012 Aug; 337(6095):658-9. PubMed ID: 22879494
[No Abstract] [Full Text] [Related]
2. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels.
Korin N; Kanapathipillai M; Matthews BD; Crescente M; Brill A; Mammoto T; Ghosh K; Jurek S; Bencherif SA; Bhatta D; Coskun AU; Feldman CL; Wagner DD; Ingber DE
Science; 2012 Aug; 337(6095):738-42. PubMed ID: 22767894
[TBL] [Abstract][Full Text] [Related]
3. The shear stress of busting blood clots.
Wootton DM; Alevriadou BR
N Engl J Med; 2012 Oct; 367(14):1361-3. PubMed ID: 23034026
[No Abstract] [Full Text] [Related]
4. Pulmonary saddle thrombus.
Jandial A; Mishra K; Kumar S; Malhotra P
QJM; 2018 Dec; 111(12):907-908. PubMed ID: 29945219
[No Abstract] [Full Text] [Related]
5. Infusion of recombinant human tissue plasminogen activator through the superior mesenteric artery in the treatment of acute mesenteric venous thrombosis.
da Motta Leal Filho JM; Santos AC; Carnevale FC; de Oliveira Sousa W; Grillo LS; Cerri GG
Ann Vasc Surg; 2011 Aug; 25(6):840.e1-4. PubMed ID: 21620665
[TBL] [Abstract][Full Text] [Related]
6. What is the optimal treatment of superior mesenteric vein/portal vein thrombosis after bariatric surgery? Is SMA-directed t-PA the answer?
Belnap L; Zaveri H; Cottam D; Surve A; Rodgers GM; Drury C
Surg Obes Relat Dis; 2017 Mar; 13(3):533-537. PubMed ID: 28159562
[No Abstract] [Full Text] [Related]
7. Splenic and superior mesenteric artery thrombolytic infusion therapy for acute portal and mesenteric vein thrombosis.
Safieddine N; Mamazza J; Common A; Prabhudesai V
Can J Surg; 2007 Feb; 50(1):68-9. PubMed ID: 17391622
[No Abstract] [Full Text] [Related]
8. Protein therapeutics for cardiovascular disease: it is all about delivery.
Ichiki T; Burnett JC
J Am Coll Cardiol; 2012 Dec; 60(24):2558-60. PubMed ID: 23158538
[No Abstract] [Full Text] [Related]
9. Thrombi--beware of red cells bearing gifts.
Ouriel K
Nat Biotechnol; 2003 Aug; 21(8):871-2. PubMed ID: 12894199
[No Abstract] [Full Text] [Related]
10. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes.
Murciano JC; Medinilla S; Eslin D; Atochina E; Cines DB; Muzykantov VR
Nat Biotechnol; 2003 Aug; 21(8):891-6. PubMed ID: 12845330
[TBL] [Abstract][Full Text] [Related]
11. Superior mesenteric arterial embolism: treatment by trans-catheter thrombo-aspiration.
Ogihara S; Yamamura S; Tomono H; Iwabuchi H; Ebihara T; Minagawa Y; Ogawa T; Kurosawa S; Yakabi K; Nakamura T
J Gastroenterol; 2003; 38(3):272-7. PubMed ID: 12673451
[TBL] [Abstract][Full Text] [Related]
12. Images in cardiovascular medicine. Regression of thrombus and electrocardiographic changes with thrombolytic therapy in acute massive pulmonary embolism.
Bozcali E; Tutpinar Y
Circulation; 2008 Nov; 118(21):2207-8. PubMed ID: 19015415
[No Abstract] [Full Text] [Related]
13. Low-dose tissue plasminogen activator in pulmonary embolism: benefit remains unclear.
Saito S; Altaqi B; Simeone F
Chest; 2011 Feb; 139(2):479-480. PubMed ID: 21285071
[No Abstract] [Full Text] [Related]
14. [Fibrinolytic therapy in mesenteric venous thrombosis: experimental study in rats].
Uccheddu A; Murgia C; Licheri S; Dazzi C; Scattone S; Cagetti M
Chir Patol Sper; 1984 Dec; 32(6):243-8. PubMed ID: 6571558
[No Abstract] [Full Text] [Related]
15. Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?
Lankeit M; Konstantinides S
Thromb Res; 2010 Dec; 126(6):e407-8. PubMed ID: 19896704
[No Abstract] [Full Text] [Related]
16. [Massive pulmonary embolism treated with selective infusion of tenecteplase].
Di Rosa S; Caramanno G; Catalano C; Andò G; Innocente P; Cutaia A; Carlino G; Vaccaro G; Vaccaro I
G Ital Cardiol (Rome); 2011 Sep; 12(9):619-22. PubMed ID: 21892224
[TBL] [Abstract][Full Text] [Related]
17. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
18. Half the dosage, similar efficacy, less bleeding: the new tissue plasminogen activator regimen for pulmonary embolism?
Davidson BL
Chest; 2010 Feb; 137(2):245-7. PubMed ID: 20133283
[No Abstract] [Full Text] [Related]
19. Systemic thrombolysis in pulmonary embolism - another paradigm falling?
Freisinger E; Reinecke H
Vasa; 2015 Mar; 44(2):156. PubMed ID: 25698395
[No Abstract] [Full Text] [Related]
20. [Thrombus in transit and submassive pulmonary thromboembolism succesfully treated with tenecteplase].
Arboine-Aguirre L; Figueroa-Calderón E; Ramírez-Rivera A; Gaxiola-Cadena B; García-Sosa A; González-Garay C
Gac Med Mex; 2017; 153(1):129-133. PubMed ID: 28128817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
